je.st
news
Deener: After three-year run, biotech stocks take a beating
2014-06-16 05:43:21| Biotech - Topix.net
Joel Roth, 65, of San Rafael, Calif., is taking Sovaldi for hepatitis c. It costs $1,000 per pill, or $84,000 for a 12-week treatment course.
Tags: run
stocks
biotech
beating
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||